Rx fee structure

I know that for many M&A transactions, banks will charge a transaction/success fee that is a percentage of the total transaction, but does the same apply to Rx? Additionally, could that change depending on whether you are working with creditor/debtor side? If you're helping the company restructure its $1bn cap stack, do you get a percentage of that figure? If you're the banker for an ad hoc group of $1bn bond holders, is it a percentage of that figure?

6 Comments
 
Most Helpful

Debtor side can get quite detailed/bespoke, likely varies by industry of company in question. Generally the answer to your question is yes and it will depend on the type of restructuring. For example, you might see an EL that includes the following: 100k/month fixed fee, financing transaction fee that includes either an amendment fee / % fee based on gross proceeds of debt / % fee based on 1L/2L debt, a sale and/or restructuring transaction fee that contemplates different scenarios ($x if in-court, $y if out-of-court), a step-up % fee based on TEV ranges, ranges based on if the debt is “materially modified” (if applicable, more than just the bank debt is modified), % of principal debt outstanding. Not an exhaustive list, but point is it could be any kind of appropriate f’d up similar combo.

Not 100% sure on creditor side, I think they are generally simpler (monthly fee + “restructuring” fee). Keep in mind that in-court fees for an ad hoc group will likely be paid out of the estates coffers and thus require court approval (same as debtor-side).

Wouldn’t be a bad idea to take a spin through some dockets and search for ELs yourself.

 

Just for additional information. Usually the court filing for the investment banker in the docket is usually called some thing like "application for retention of [RX IB] as investment banker" and the engagement letter is sometimes attached in the document as an Exhibit. Otherwise, the filing itself will be explicit about the fee structure

 

Dolores corrupti odit inventore adipisci amet accusantium. Quidem et hic fugiat. Sunt non omnis quos soluta sed nam. Unde ea soluta dolores exercitationem. Debitis nihil atque enim.

Quis est fugit maiores maiores. Deleniti omnis odit molestias ipsam voluptatem a et. Fugiat molestias eligendi mollitia iste ea. Velit temporibus nisi quia itaque nisi esse aliquam.

Career Advancement Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.3%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.1%

Overall Employee Satisfaction

June 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Morgan Stanley 02 98.8%
  • Evercore 01 98.3%
  • BMO Capital Markets 12 97.7%
  • Banco Santander 01 97.1%

Professional Growth Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 05 98.3%
  • JPMorgan No 97.7%
  • Goldman Sachs 02 97.1%

Total Avg Compensation

June 2026 Investment Banking

  • Vice President (14) $434
  • Associates (44) $258
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (13) $156
  • 1st Year Analyst (79) $150
  • Intern/Summer Analyst (73) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
kanon's picture
kanon
99.0
3
Secyh62's picture
Secyh62
99.0
4
BankonBanking's picture
BankonBanking
99.0
5
dosk17's picture
dosk17
98.9
6
CompBanker's picture
CompBanker
98.9
7
GameTheory's picture
GameTheory
98.9
8
DrApeman's picture
DrApeman
98.9
9
Betsy Massar's picture
Betsy Massar
98.9
10
Linda Abraham's picture
Linda Abraham
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”